Activotec announces further business expansion…
January 7, 2009
Activotec has announced a major expansion of its Cambridge, UK Headquarters and investment in new sales and production staff to meet the strong international demand for its Activo-P11 Peptide Synthesizer, an easy to use instrument for synthesis of very high quality peptides. Chris Littlewood, Chief Executive of Activotec, commented "2008 peptide synthesizer sales have exceeded [...]
A2 Technologies Announces Patent License Agreement with the Boeing Company
January 7, 2009
Danbury, CT, January 07, 2009 --(PR.com)-- A2 Technologies today announced they have entered into a patent license with the Boeing Company allowing the use of Boeing patents in association with the development, manufacture and sale of A2 Technologies’ FTIR Spectrometers. The license will permit A2 Technologies to utilize the patents in the application of A2’s [...]
Volcano Announces Closing of Axsun Technologies Acquisition
January 7, 2009
SAN DIEGO, Jan. 7 -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has closed its previously announced acquisition of Axsun Technologies, Inc. Axsun is a leading developer and manufacturer of lasers and optical [...]
January 7, 2009
The Woodlands, TX - January 7, 2009. Rigaku Americas Corporation today announced that the Department of Chemistry and Biochemistry at the Texas State University has purchased a Rigaku SCXmini™ benchtop small molecule X-ray diffraction (XRD) crystallography instrument for Cyber-enabled Small Molecule Structure Analysis for Research and Educational Purposes as funded by a Major Research Instrumentation [...]
Cell Biosciences Delivers Next Generation System to Stanford University
January 6, 2009
PALO ALTO, Calif., Jan. 6 -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the placement of a next-generation protein analysis system prototype, the Cell Biosciences CB1000, at the Stanford University School of Medicine. David Hirschberg, Ph.D., Director of the Human Immune Monitoring Center (HIMC) at Stanford, will [...]
Implant Sciences Appoints Glenn D. Bolduc as President and Chief Executive Officer
January 6, 2009
WAKEFIELD, Mass.--Implant Sciences Corporation (NYSE Alternext US: IMX), a supplier of sophisticated systems and sensors for the homeland security market and related industries, today announced the appointment of Glenn D. Bolduc as the Company’s new President and Chief Executive Officer. In addition, the Board of Directors has appointed Mr. Bolduc as a member of the [...]
January 6, 2009
SAN DIEGO--Accelrys, Inc. (NASDAQ: ACCL) today reported that Mark Emkjer, its President and Chief Executive Officer has resigned as an officer and director of the company, effective January 5, 2009. Mr. Emkjer will remain employed by the Company until February 1, 2009 to assist in transitioning his role and responsibilities. The Company’s Board of Directors [...]
Microfluidics and HORIBA Instruments, Inc. Announce the Formalization of Their Partnership
January 6, 2009
NEWTON, Mass.--Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTCBB: MFLU) and HORIBA Instruments, Inc. are pleased to announce that their long standing partnership has been formalized. Previously, the two companies have shared marketing efforts, such as seminars and joint customer presentations. From this point forward, these efforts also will include shared exhibit booths [...]
GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
January 6, 2009
ST. JOSEPH, Mich., Jan. 6 -- GeneGo, Inc., a leading provider of software and high quality manually curated databases for systems biology and pathway analysis, today announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Schering Pharma has programs for cancer, cardiovascular diseases and gynecological therapies and GeneGo [...]
January 6, 2009
CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a world leader in oligonucleotide production, announces a license agreement with LI-COR Biosciences to manufacture oligos for worldwide sale using the unique LI-COR IRDye 700, IRDye 800, and IRDye 800CW infrared dyes. As of November 15, 2008, LI-COR no longer manufactures custom IRDye labeled oligos; LI-COR now recommends [...]

